Disease-A-Month
Volume 55, Issue 1 , Pages 6-38 , January 2009

Cocaine: History, Social Implications, and Toxicity—A Review

References 

  1. Altman AJ, Albert DM, Fournier GA. Cocaine's use in ophthalmology: our 100 year heritage. Surv Ophthalmol. 1985;29:300–307
  2. Gay GR, Inaba DS, Sheperd CW, et al. Cocaine: history, epidemiology, human pharmacology and treatment (A perspective on a new debut for an old girl). Clin Toxicol. 1975;8:149–178
  3. Piek J, Lidke G, Terberger Th. Chirurgische Universitatsklinik Rostock, Abeilung fur Neurochirurgie, Rostock. Ancient trephinations in Neolithic people-evidence for stone age neurosurgery? Nat Proc hdl:10101/npre.2008.1615.1. Posted 21 Feb 2008.
  4. Monardes N. Joyfull Newes Out of the Newe Founde Worlde. New York, NY: Alfred Knopf; 1925;
  5. May CD. How Coca-Cola obtains its coca. The New York Times. 1998;July 1. Accessed December 4, 2007
  6. Benson D. Coca kick in drinks spurs export fears. The Washington Times. 2004;April 20
  7. Johnson C. The Legal Importation of Coca Leaf. http://www.uic.edu/classes/osci/osci590/9_3%20The%20Legal%20Importation%20of%20Coca%20Leaf.htm. Accessed on February 11, 2007.
  8. Brecher EM. Editors of Consumer Reports Magazine (The Consumers Union Report on licit and illicit drugs). Consumer Reports Magazine. 1972;
  9. 63rd Congress. The Harrison Narcotic Act (1914). Public Law No. 223, approved December 17, 1914.
  10. National Survey on Drug Use and Health. http://www.samhsa.gov/Accessed June 1, 2008
  11. Drug Abuse Warning Network, 2004: National estimates of drug-related emergency department visits. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. http://DAWNinfo.samhsa.gov/.
  12. Office of Applied Studies. Year-end 1999 emergency department data from drug abuse warning network. Rockville, MD: Substance Abuse and Mental Health Services Administration, August 2000. DHSS publication no. (SMA)00-3462.
  13. Traub SJ, Hoffman RS, Nelson LS. Body packing—the internal concealment of illicit drugs. New Engl J Med. 2003;349(26):2519–2526
  14. Caruana DS, Weinbach B, Goerg D, et al. Cocaine-packet ingestion. Ann Intern Med. 1984;100(1):73–74
  15. Kashani J, Ruha AM. Methamphetamine toxicity secondary to intravaginal body stuffing. J Toxicol Clin Toxicol. 2004;42(7):987–989
  16. Shanti CM, Lucas CE. Cocaine and the critical care challenge. Crit Care Med. 2003;31(6):1851–1859
  17. Boghdadi MS, Henning RJ. Cocaine: pathophysiology and clinical toxicology. Heart Lung. 1997;26(6):466–483
  18. Warner EA. Cocaine abuse. Ann Intern Med. 1993;119(3):226–235
  19. Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988;17(11):1243–1247
  20. Koren G, Klein J, Forman R, et al. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol. 1992;32:671–675
  21. Chychula NM, Okore C. The cocaine epidemic: a comprehensive review of use, abuse and dependence. Nurse Pract. 1990;15(7):31–39
  22. Stephens BG, Jentzen JM, Karch S, et al. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol. 2004;25(1):1–10
  23. Jatlow P. Cocaethylene: pharmacologic activity and clinical significance. Ther Drug Monit. 1993;15(6):533–536
  24. McCance EF, Price LH, Kosten TR, et al. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther. 1995;274:215–223
  25. McKinney CD, Postiglione KF, Herold DA. Benzocaine-adulterated street cocaine in association with methemoglobinemia. Clin Chem. 1992;38(4):596–597
  26. Prasad RS, Kodali VR, Kuraijam GS, et al. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med. 2003;10:353–356
  27. Wood DM, Webster E, Martinez D, et al. Case report: survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care. 2002;6(5):456–459
  28. O'Callaghan WG, Joyce N, Counihan HE. Unusual strychnine poisoning and its treatment: report of eight cases. BMJ. 1982;285:478
  29. Ursitti F, Klein J, Koren G. Confirmation of cocaine use during pregnancy: a critical review. Ther Drug Monit. 2001;23(4):347–353
  30. Burke WM, Ravi NV, Dhopesh V, et al. Prolonged presence of metabolite in urine after compulsive cocaine use. J Clin Psychiatry. 1990;51(4):145–148
  31. Weiss RD, Gawin FH. Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. Am J Med. 1988;85:879–880
  32. Baselt RC, Baselt DR. Little cross-reactivity of local anesthetics with Abuscreen, EMIT d.a.u., and TDX immunoassays for cocaine metabolite (letter). Clin Chem. 1987;33(5):747
  33. Mazor SS, Mycyk MB, Wills BK, et al. Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med. 2006;13:340–341
  34. Mikkelsen SL, Ash KO. Adulterants causing false negatives in illicit drug testing. Clin Chem. 1988;34(11):2233–2236
  35. Karch SB. Introduction to the forensic pathology of cocaine. Am J Forensic Med Pathol. 1991;12(2):126–131
  36. Gruszecki AC, Robinson CA, Embry JH, et al. Correlation of the incidence of cocaine and cocaethylene in hair and postmortem biologic samples. Am J Forensic Med Pathol. 2000;21(2):166–171
  37. Roldan CJ. Toxicity, Cocaine. http://www.emedicine.com/med/topic400.htm. Accessed June 1, 2008.
  38. Catterall WA, Mackie K. Local anesthetics. In:  Brunton LJ,  Parker KL,  Buxton I, et al. editor. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed.. New York, NY: McGraw Hill; 2006;
  39. Leshner AI. Molecular mechanisms of cocaine addiction (letter). New Engl J Med. 1996;335(2):128–129
  40. Knuepfer M. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther. 2003;97(3):181–222
  41. Hoffman RS. Cocaine. In:  Flomenbaum NE,  Goldfrank LR,  Hoffman RS, et al. editor. Goldfrank's Toxicologic Emergencies. 8th ed.. New York, NY: McGraw Hill; 2006;p. 1133–1146
  42. Lason W. Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol J Pharmacol. 2001;53:57–60
  43. O'Dell L, George FR, Ritz MC. Antidepressant drugs appear to enhance cocaine-induced toxicity. Exp Clin Psychpharmacol. 2000;8(1):133–141
  44. Liu D, Hariman RJ, Bauman JL. Cocaine concentration-effect relationship in the presence and absence of lidocaine: evidence of competitive binding between cocaine and lidocaine. J Pharmacol Exp Ther. 1996;276(2):568–577
  45. McCord J, Hani J, Hollander JE. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association acute cardiac care committee of the council on clinical cardiology. Circulation. 2008;117(14):1897–1907
  46. Tella SR, Schindler CW, Goldberg SR. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther. 1993;267(1):153–162
  47. Dattilo PB, Hailpern SM, Fearon K, et al. Beta blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51(2):117–125
  48. Laizure SC, Mandrell T, Gades NM, et al. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos. 2003;31(1):16–20
  49. Foltin W, Fischman MW, Pedroso JJ, et al. Marijuana and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav. 1987;28(4):459–464
  50. Lexi-comp Online. Lexi-Interact. 1978-2008 Lexi-Comp, Inc. Retrieved June 2008.
  51. Jeffcoat A, Perez-Reyes M, Hill J. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Am Soc Pharmacol Exp Therapeut 17(2):153-9.
  52. Klasco RK, editor. Cocaine. POISINDEX System. Thomson Healthcare, Greenwood Village, CO (Edition expired 9/2008).
  53. Leikin J, Paloucek F. Cocaine. In: Poisoning and Toxicology Handbook. 4th ed.. New York, NY: CRC Press; 2008;p. 213
  54. Baslet R. Cocaine. In: Disposition of Toxic Drugs and Chemicals in Man. 6th ed.. Foster City, CA: Biomedical Publications; 2002;p. 247–253
  55. Maurer H, Sauer C, Theobald D. Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Drug Monit. 2006;28(3):447–453
  56. Jufer R, Walsh S, Cone E, et al. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol. 2006;30:458–462
  57. Huestis M, Darwin W, Shimomura E, et al. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol. 2007;21:462–468
  58. Cone E, Tsadic A, Oyler H, et al. Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit. 1998;20(5):556–560
  59. Kolbrich E, Barnes A, Gorelick D, et al. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol. 2006;30:501–511
  60. Nedamanee K, Gorelick DA, Josephson MA, et al. Myocardial ischemia during cocaine withdrawal. Ann Int Med. 1989;111:876–880
  61. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. New Engl J Med. 2001;345:351–358
  62. Tennant CC. Cocaine use and cardiovascular complications (Department of Aged Care and Rehab, Hornsby Kur-Ring-Gai Hospital, Hornsby, NSW). Med J Aust. 2002;177(5):260–262
  63. Hollander J, Todd K, Green G, et al. Chest pain associated with cocaine: An assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med. 1995;26:671–676
  64. http://www.cnn.com/2008/HEALTH/03/17/cocaine.heart.ap/index.html
  65. Hollander JE. Management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267–1272
  66. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain (Cocaine Associated Chest Pain (COCHPA) Study Group). Acad Emerg Med. 1994;1:330–339
  67. Mittleman MA, Mintzewr D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation. 1999;99:2737–2741
  68. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. N Engl J Med. 1989;321:1557–1562
  69. Flores ED, Lange RA, Cigarrora RG, et al. Effects of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol. 1990;16:74–79
  70. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine induced coronary vasoconstriction by beta-adrenergic vasoconstriction by beta-adrenergic blockade. Ann Int Med. 1990;112:897–903
  71. Mo W, Singh AK, Arruda JA, et al. Role of nitric oxide in cocaine induced acute hypertension. Am J Hypertens. 1998;11:708–714
  72. Roldan CJ, Habal R. Toxicity, Cocaine, WebMD, Sep 22, 2006. http://www.emedicine.com/med/topic400.htm.
  73. Rezkella SH, Mazza JJ, Kloner RA, et al. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol. 1993;72:243–246
  74. Kugelmass AD, Oda A, Monahan K, et al. Activation of human platelets by cocaine. Circulation. 1993;88:876–883
  75. Rinder HM, Ault KA, Jatlow PI, et al. Platelet alpha-granule release in cocaine users. Circulation. 1994;90:1162–1167
  76. Moliterno DJ, Lange RA, Gerard RD, et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med. 1994;96:492–496
  77. Kolodgie FD, Virmani R, Cornhill JF, et al. Increases in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol. 1991;17:1553–1560
  78. Kolodgie FD, Wilson PS, Mergner WJ, et al. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999;66:109–122
  79. Gan X, Zhang L, Berger O, et al. Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol. 1999;91:68–76
  80. Dattilo PB, Fearon K, Sohal D. B-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51:117–125
  81. Burnett LB. Toxicity, Cocaine. http://www.emedicine.com/EMERG/topic102.htm.
  82. Goldfrank LR, Flomenbaum NE, Lewin NA, et al. In: Goldfrank's Toxicologic Emergencies. 7th ed.. New York: McGraw-Hill; 2002;p. 1007–1008
  83. Weiner RS, Lockhart JT, Schwartz RG. Dilated cardiomyopathy and cocaine abuse. Am J Med. 1986;81:699–701
  84. Johnson MN, Karas SP, Hursey TL, et al. Cocaine binging produces left ventricular dysfunction. Circulation. 1989;80:94(suppl 21):15
  85. Konkol RJ, Olsen GD. Prenatal cocaine exposure. In: Boca Raton, FL: CRC Press; 1996;p. 47;84
  86. Tashkin DP, Kleerup EC, Koyal SN, et al. Acute effects of inhaled and IV cocaine on airway dynamics. Chest. 1996;110:904–910
  87. Callaway C, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med. 1994;24:68–76
  88. Pagala M, Amaladevi B, Azad D, et al. Effect of cocaine in leakage of creatine kinase from isolated fast and slow muscles of rat. Life Sci. 1995;57:1569–1578
  89. Brazeau G, McArdles A, Jackson M. Effects of cocaine on leakage of creatine kinase from skeletal muscle; in vitro and in vivo studies in mice. Life Sci. 1995;57:751–756
  90. Ruttenber JA, McNally HB, Weitl CV, et al. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol. 1999;20(2):120–127
  91. Woods JR. Maternal and transplacental effects of cocaine. Ann NY Acad Sci. 1998;846(1):1–11
  92. Chiriboga CA, Brust JC, Bateman D, et al. Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics. 1999;103(1):79–85
  93. Chiriboga CA. Neurological correlates if fetal cocaine exposure: cocaine effects on the developing brain. Ann NY Acad Sci. 1998;846:109–125
  94. Bauer CR, Shankaren S, Bada HS, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159:824–834
  95. Manju M, Chmielowiec S, Andres R, et al. Cocaine alters placental production of thromboxane and prostacyclin. Am J Obstet Gynecol. 1994;171:965–969

PII: S0011-5029(08)00136-3

doi: 10.1016/j.disamonth.2008.10.002

Disease-A-Month
Volume 55, Issue 1 , Pages 6-38 , January 2009

Article Tools

* Image Usage & Resolution